Back to KROS

GOLDMAN SACHS GROUP INC → KROS

GOLDMAN SACHS GROUP INC KROS Position History

Keros Therapeutics, Inc. • Healthcare

Quarters held
16
Latest value
$1.2M
Q3 2026
Peak value
$13.6M
First seen
Q2 2025

Dollar value over time

Show data table
PeriodPosition value
Q2 2025$5.6M
Q2 2025$6M
Q2 2025$162K
Q3 2025$13.6M
Q3 2025$7.1M
Q3 2025$191K
Q4 2025$6M
Q4 2025$6M
Q4 2025$6M
Q4 2025$6M
Q1 2026$1.3M
Q1 2026$1.2M
Q2 2026$942K
Q2 2026$961K
Q3 2026$1.7M
Q3 2026$1.2M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$1.2M102.8K——
Q3 2026$1.7M151.3K——
Q2 2026$961K89.8K——
Q2 2026$942K88.1K——
Q1 2026$1.2M108.3K——
Q1 2026$1.3M116.1K——
Q4 2025$6M295.9K——
Q4 2025$6M294.6K——
Q4 2025$6M294.6K——
Q4 2025$6M295.9K——
Q3 2025$191K12.1K——
Q3 2025$7.1M450.7K——
Q3 2025$13.6M862.7K——
Q2 2025$162K12.1K——
Q2 2025$6M450.1K——
Q2 2025$5.6M421.3K——

Other funds holding KROS

$288.7M
$240.4M
$182.8M
$175.4M
$171.8M
$163.6M
$161.9M
$144.3M

Other GOLDMAN SACHS GROUP INC positions

NVDA

NVIDIA CORPORATION

$37B
AAPL

APPLE INC

$31.7B
NVDA

NVIDIA CORPORATION

$31.3B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.3B
AAPL

APPLE INC

$26.9B
NVDA

NVIDIA CORPORATION

$26.5B